WHEATLAND ADVISORS INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
WHEATLAND ADVISORS INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2020$802,000
+3.4%
9,313
-2.6%
3.33%
-15.7%
Q1 2020$776,000
-58.0%
9,563
-56.7%
3.94%
+67.7%
Q4 2019$1,846,000
-30.2%
22,078
-27.0%
2.35%
-2.0%
Q3 2019$2,644,000
-20.2%
30,228
-25.3%
2.40%
-3.9%
Q2 2019$3,312,0000.0%40,443
-0.7%
2.50%
-1.1%
Q1 2019$3,312,000
+21.7%
40,728
-1.5%
2.53%
+6.3%
Q4 2018$2,722,000
-16.0%
41,352
-1.7%
2.38%
-2.5%
Q3 2018$3,242,000
+4.4%
42,0510.0%2.44%
-2.9%
Q2 2018$3,105,000
+13.3%
42,051
-0.2%
2.51%
+10.9%
Q1 2018$2,741,000
+0.3%
42,150
-0.4%
2.26%
+2.3%
Q4 2017$2,734,000
+2.9%
42,299
-0.1%
2.21%
-2.6%
Q3 2017$2,656,000
+2.5%
42,324
-1.2%
2.27%
-2.7%
Q2 2017$2,592,000
+12.5%
42,818
-3.6%
2.34%
+13.6%
Q1 2017$2,303,000
+11.6%
44,417
-4.6%
2.06%
+12.2%
Q4 2016$2,064,000
-7.2%
46,542
-0.4%
1.83%
-12.5%
Q3 2016$2,225,000
+5.2%
46,741
-0.1%
2.09%
+3.0%
Q2 2016$2,115,000
+9.1%
46,765
-0.8%
2.03%
+2.6%
Q1 2016$1,938,000
+6.6%
47,164
-1.0%
1.98%
+6.6%
Q4 2015$1,818,000
+16.0%
47,664
-0.1%
1.86%
+9.3%
Q3 2015$1,567,000
-53.0%
47,713
+0.0%
1.70%
-46.9%
Q2 2015$3,336,000
+4.5%
47,709
+2.4%
3.20%
+0.7%
Q1 2015$3,193,000
-6.3%
46,607
+0.2%
3.18%
-4.2%
Q4 2014$3,408,000
+2.4%
46,505
+0.3%
3.32%
-0.1%
Q3 2014$3,327,000
-0.5%
46,353
+0.2%
3.32%
+9.3%
Q2 2014$3,344,000
-2.4%
46,252
-0.6%
3.04%
-13.1%
Q1 2014$3,425,000
+6.4%
46,550
+0.5%
3.50%
+3.6%
Q4 2013$3,220,00046,3003.38%
Other shareholders
BAXTER INTL INC shareholders Q2 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders